The table below shows TG THERAPEUTICS, INC.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$24.77M
-$40.52M
-$31.41M
-$176.17M
-$295.63M
-$214.51M
Capital expenditure
$214.00K
$45.00K
$0.00
$14.00K
$401.00K
$357.00K
Investing cash flow
$13.80M
-$1.04M
-$50.65M
-$20.01M
-$332.00K
-$24.51M
Dividends paid
-
-
-
-
TGTX operating cash flow (10-K history)
TG THERAPEUTICS, INC. reported operating cash flow of -$24.77M for fiscal year 2025. That is up 38.9% from -$40.52M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$5.19M (FY 2012) to -$24.77M. Figures come from the company's audited annual reports as filed with the SEC.
